BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:... ( NOVATO Calif. Sept. 30 /- BioMarin Ph...)

HOME >> BIOLOGY >> TECHNOLOGY

BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET

Date:9/30/2009

NOVATO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, October 28, at 5:00 p.m. ET to discuss third quarter 2009 financial results.

    U.S. / Canada Dial-in Number:  800.299.6183
    International Dial-in Number:  617.801.9713
    Participant Code: 51404008
    Replay Dial-in Number: 888.286.8010
    Replay International Dial-in Number: 617.801.6888
    Replay Code: 51416825

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development fo
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. BioMarin to Present at the Morgan Stanley Healthcare Conference
2. BioMarin to Present at the Baird Healthcare Conference
3. BioMarin to Present at the Jefferies Healthcare Conference
4. BioMarin to Present at the Goldman Sachs Healthcare Conference
5. BioMarin to Present at the Deutsche Bank Health Care Conference
6. BioMarin to Present at the Baird Growth Stock Conference
7. BioMarin Announces First Quarter 2009 Financial Results
8. BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET)
9. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
10. BioMarin to Present at the 4th Annual Citi Biotech Day
11. BioMarins Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA

Post Your Comments:

(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015 23andMe, ... of Kate Black as Privacy Officer and ... federal, and state privacy laws as well as health ... regulatory team, she will be responsible for reviewing, updating ... customers in the U.S. and abroad. She joined the ...

(Date:2/26/2015)... 26, 2015 Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today reported ... goals, other key objectives, and financial guidance. Synageva,s ... at 4:30 p.m. EST to review the financial ... participate in today,s call by telephone, please dial ...

(Date:2/26/2015)... , Feb. 26, 2015 Protiviti ( ... latest version of the Governance Portal , designed ... risk and compliance (GRC) tasks across multiple business units ... updated to help customers better align their controls with ... Treadway Commission ) requirements. In response to client feedback, ...

(Date:2/26/2015)... (PRWEB) February 26, 2015 The Movement ... demonstration to support life extension technologies and awareness. The ... Universal Coordinated Time, on March 21st 2015, in a ... , Eric Schulke, Founder of MILE, says, “Our ... with urgency. The Movement for Indefinite Life Extension is ...

[0] 23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel [0] Synageva BioPharma Reports 2014 Full Year Financial Results [0] Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units [0] Indefinite Life Extension Activists Organize Online Demonstration

... - Another dismal report on venture capital investing ... state must do to attract more private equity financing ... debate could turn out to be the State of ... meeting of the investment board, which is the ninth ...

... Madison, Wis. -- Distance learning is about more ... physical classroom, says Michael Schrage. Rather, technology is a ... is taught, how it is taught, and what the ... itself. , ,Schrage, a research associate at MIT Media ...

... the Dodge Industrial Park here is providing needed growing room ... API Inc., built the facility on 28 acres in ... separate locations in Hartford. It moved into the new space ... as Automated Peripherals Inc., more than twice the space available ...

Cached Biology Technology:State investment board keeps an eye on Wisconsin's tech trends 2 State investment board keeps an eye on Wisconsin's tech trends 3 Schrage: Don't think of distance learning as just automation 2 Schrage: Don't think of distance learning as just automation 3

State investment board keeps an eye on Wisconsin's tech trends Schrage: Don't think of distance learning as just automation New facility giving API needed room to grow

(Date:2/10/2015)... Alere Inc. (NYSE: ALR), a global leader ... the quarter ended December 31, 2014. ... Alere said, "We made substantial progress in the ... leader in rapid diagnostics and delivering against our ... in early January enabled us to substantially reduce ...

(Date:2/5/2015)... 5, 2015 Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...

(Date:2/5/2015)... 27, 2015 Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...

[1] Alere Inc. Announces Fourth Quarter 2014 Results [0] Marken Launches New Patient-Centric Campaign [1] Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test

... of the same emotions as a human listening to music, suggests ... Evolutionary Neuroscience . "We found that the ... breeding state that are listening to male birdsong, and in people ... the research as an undergraduate at Emory University. For male ...

... of Second Life, female avatars expose substantially more skin ... to research published December 26 in the open access ... colleagues from Laval University, Canada. The human ... and cultural constraints, so measuring people,s propensity to reveal ...

... York University biologists have identified how a vital protein is ... chromosome that plays a significant role in cell division. Their ... insights into the factors behind the production of abnormal numbers ... issue of the journal the Proceedings of the National ...

Cached Biology News:Birdsong study pecks theory that music is uniquely human 2 Birdsong study pecks theory that music is uniquely human 3 NYU biologists identify proteins vital to chromosome segregation 2

Birdsong study pecks theory that music is uniquely human Virtual women reveal more skin, regardless of body proportions NYU biologists identify proteins vital to chromosome segregation

...

Biology Products:

Silencer Pre-designed siRNA, standard purity from Ambion Custom siRNA, HPLC purified, annealed from Ambion Silencer Validated siRNA 5 nmol from Ambion Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion